XPR – Lifestyle Demo
Author:
NetraMark Holdings Inc.
NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference
March 19, 2026
NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data
March 11, 2026